Consultant

Prof Naila Arebi

Consultant Gastroenterologist
MD, MSc, PhD, FRCP
naila_arebi.jpg

Professor Arebi is a consultant gastroenterologist with an interest in inflammatory bowel disease. She leads the IBD Service at St Mark's National Bowel Hospital and won awards for quality improvement initiatives. She is an elected member of the European Crohn's and Colitis organisation and the British Society of Gastroenterology.

Gastroenterology
English
In-person, Phone call, Video call
New £300 (follow-up £200)
Request an appointment

Treatments

Available treatments from Prof Naila Arebi
1 / 7

Coeliac disease treatment

Coeliac disease is usually suspected when someone has severe abdominal symptoms and also shows signs of malnourishment or anaemia

Duodenal ulcer treatment

Testing and treatment for an ulcer in your intestines. Treatments include medication or surgery.

Heartburn and gastro-oesophageal treatments

At The London Clinic we provide a private heartburn treatment service.

Colonoscopy

Our first-class colonoscopy service screens for bowel cancer and investigates other problems affecting the colon. Available Saturdays as well as weekdays.

Flexible sigmoidoscopy

We provide a first-class sigmoidoscopy service to diagnose and monitor conditions of the large bowel.

Gastroscopy

Our first-class gastroscopy service diagnoses conditions affecting the oesophagus, stomach and duodenum.

BRAVO pH testing

BRAVO pH testing is a minimally invasive investigation that evaluates the level of acidity in your oesophagus and is used as a diagnostic tool.

Related conditions

1 / 4

Crohn’s disease

At The London Clinic we provide a private Crohn’s disease treatment service. Book a consultation with one of our world renowned specialists and start your

3 treatments available

Ulcerative colitis

At The London Clinic we provide a private ulcerative colitis treatment service. Book a consultation with one of our world renowned specialists.

2 treatments available

Heartburn and gastro-oesophageal reflux

GORD is the acronym for gastro-oesophageal reflux disease, which is what most people would refer to as heartburn.

1 treatment available

Coeliac disease

Coeliac disease is an allergic response to the molecule gluten, which is found in wheat, rye and barley.

1 treatment available

Bio

Professor Arebi qualified as a doctor in Malta and completed her higher training in the UK. She is a key opinion leader in her field of Inflammatory Bowel Disease (IBD). She leads the IBD Service at St Mark's National Bowel Hospital and won awards for quality improvement initiatives.

She is an elected member of the European Crohn's and Colitis organisation and the British Society of Gastroenterology. She has an active research portfolio in quality improvement, epidemiology and novel treatment approached to IBD.

Professor Naila Arebi is a keen cyclist.

More information

116 Harley Street
London W1G 7JL

Dr Naila Arebi is available through The London Clinic's Connect service for video consultations.

Book a video consultation

  • Consultant Gastroenterologist
    St Mark's National Bowel Hospital
  • Honorary Senior Lecturer
    Imperial College, London
  • Assessment and investigation of intestinal symptoms including diarrhoea, constipation, rectal bleeding, weight loss, heartburn
  • Assessment and management of ulcerative colitis and crohn’s disease
  • Investigations for heartburn and reflux with bravo pH capsule
  • Year qualified 1989
  • Malta Medical School 1989

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project

Year: 2019
BMJ Open Qual

Surgery versus infliximab for Crohn's disease: should there be a change in clinical practice?

Year: 2020
Lancet Gatroenterol Hepatol

Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study

Year: 2019
World J Gastroenterol

A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence

Year: 2022
Published by: Journal of Crohn's and Colitis 
Authors: Wong, C van Oostrom, J Bossuyt, P Pittet, V Hanzel, J Samaan, M Tripathi, M Czuber-Dochan, W Burisch, J Leone, S Saldana, R Baert, F Kopylov, U Jaghult, S Adamina, M Gecse, K Arebi, N

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

Year: 2022
Published by: Lancet Gastroenterology and Hepatology
Authors: Papamichael, Konstantinos Afif, Waqqas Drobne, David Dubinsky, Marla C. Ferrante, Marc Irving, Peter M. Kamperidis, Nikolaos Kobayashi, Taku Kotze, Paulo G. Lambert, Jo Noor, Nurulamin M. Roblin, Xavier Roda, Giulia Vande Casteele, Niels Yarur, Andres J. Arebi, Naila Danese, Silvio Paul, Stephane Sandborn, William J. Vermeire, Severine Cheifetz, Adam S. Peyrin-Biroulet, Laurent

Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease

Year: 2022
Published by: Gastroenterology
Authors: ariente, B Torres, J Burisch, J Arebi, N Barberio, B Duricova, D Ellul, P Goldis, A Kaimakliotis, I Katsanos, K Krznaric, Z McNamara, D Pedersen, N Sebastian, S Azahaf, M Weimers, P Lung, P Lacognata, C Horak, M Christodoulou, D Domislovic, V Murphy, I Lambert, J Ungaro, R Colombel, JF

  • BMJ commended award for IBD services
  • Brian Turley Award for IBD services and patient partnerships
  • NHS Clinical Excellence Awards

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.

Get in touch